Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease
1
Department of Medical Technology, Kagawa Prefectural University of Health Sciences, 281-1, Hara, Mure-Cho, Takamatsu, Kagawa 761-0123, Japan
2
Department of Gastroenterology and Neurology, Kagawa University School of Medicine, Kagawa 761-0123, Japan
*
Author to whom correspondence should be addressed.
Nutrients 2018, 10(1), 88; https://doi.org/10.3390/nu10010088
Received: 14 December 2017 / Revised: 4 January 2018 / Accepted: 5 January 2018 / Published: 14 January 2018
(This article belongs to the Special Issue Dietary Zn and Human Health)
Zinc (Zn) is an essential trace element which has favorable antioxidant, anti-inflammatory, and apoptotic effects. The liver mainly plays a crucial role in maintaining systemic Zn homeostasis. Therefore, the occurrence of chronic liver diseases, such as chronic hepatitis, liver cirrhosis, or fatty liver, results in the impairment of Zn metabolism, and subsequently Zn deficiency. Zn deficiency causes plenty of metabolic abnormalities, including insulin resistance, hepatic steatosis and hepatic encephalopathy. Inversely, metabolic abnormalities like hypoalbuminemia in patients with liver cirrhosis often result in Zn deficiency. Recent studies have revealed the putative mechanisms by which Zn deficiency evokes a variety of metabolic abnormalities in chronic liver disease. Zn supplementation has shown beneficial effects on such metabolic abnormalities in experimental models and actual patients with chronic liver disease. This review summarizes the pathogenesis of metabolic abnormalities deriving from Zn deficiency and the favorable effects of Zn administration in patients with chronic liver disease. In addition, we also highlight the interactions between Zn and other trace elements, vitamins, amino acids, or hormones in such patients.
View Full-Text
Keywords:
zinc deficiency; HCV-related chronic liver disease; nonalcoholic steatohepatitis; liver cirrhosis; insulin resistance; hepatic steatosis; hepatic encephalopathy; iron overload; lipid peroxidation; insulin-like growth factor-1
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Himoto, T.; Masaki, T. Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease. Nutrients 2018, 10, 88. https://doi.org/10.3390/nu10010088
AMA Style
Himoto T, Masaki T. Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease. Nutrients. 2018; 10(1):88. https://doi.org/10.3390/nu10010088
Chicago/Turabian StyleHimoto, Takashi, and Tsutomu Masaki. 2018. "Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease" Nutrients 10, no. 1: 88. https://doi.org/10.3390/nu10010088
Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
